Cyclosporin A Versus Intravenous Cyclophosphamide in the Treatment of Lupus nephritis: The Cyclofa-Lune Study

被引：0
|
作者：
Pesickova, P. [1 ]
Zavada, Z. [2 ]
Rysava, R. [1 ]
Horak, H. [3 ]
Hrncir, C. . [4 ,5 ]
Rychlik, R. [6 ,7 ]
Vitova, V. [8 ]
Lukac, L. [9 ]
Dostal, D. [2 ]
Tesar, T. [1 ]
机构：
[1] Gen Univ Hosp, Dept Nephrol, Prague, Czech Republic
[2] Charles Univ Prague, Fac Med 1, Inst Rheumatol, Prague, Czech Republic
[3] Univ Hosp, Dept Med, Olomouc, Czech Republic
[4] Univ Hosp, Dept Med 2, Hradec Kralove, Czech Republic
[5] Charles Univ Prague, Fac Med, Hradec Kralove, Czech Republic
[6] Kralovske Vinohrady Univ Hosp, Dept Med 2, Prague, Czech Republic
[7] Charles Univ Prague, Fac Med 3, Prague, Czech Republic
[8] Dept Med, Ceske Budejovice, Czech Republic
[9] Inst Rheumatol Dis, Piestany, Slovakia
来源：
KIDNEY & BLOOD PRESSURE RESEARCH | 2010年 / 33卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
6
引用
收藏
页码：316 / 316
页数：1
相关论文
共 50 条
  • [1] Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study
    Zavada, J.
    Pesickova, S. S.
    Rysava, R.
    Olejarova, M.
    Horak, P.
    Hrncir, Z.
    Rychlik, I.
    Havrda, M.
    Vitova, J.
    Lukac, J.
    Rovensky, J.
    Tegzova, D.
    Boehmova, J.
    Zadrazil, J.
    Hana, J.
    Dostal, C.
    Tesar, V.
    LUPUS, 2010, 19 (11) : 1281 - 1289
  • [2] Cyclofa-lune (2002) lupus nephritis-randomized controlled multicentric therapeutic comparative study with cyclosporin a versus cyclophosphamide:: Running evaluation
    Dostál, C
    Tesar, V
    Rysava, R
    Rovensky, J
    Rychlik, I
    Hrnèíl, Z
    Horak, P
    Vlasakova, V
    Tesar, V
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 223 - 224
  • [3] Extended follow-up of the CYCLOFA-LUNE trial comparing two sequential induction and maintenance treatment regimens for proliferative lupus nephritis based either on cyclophosphamide or on cyclosporine A
    Zavada, J.
    Pesickova, S. Sinikka
    Rysava, R.
    Horak, P.
    Hrncir, Z.
    Lukac, J.
    Rovensky, J.
    Vitova, J.
    Havrda, M.
    Rychlik, I.
    Boehmova, J.
    Vlasakova, V.
    Slatinska, J.
    Zadrazil, J.
    Olejarova, M.
    Tegzova, D.
    Tesar, V.
    LUPUS, 2014, 23 (01) : 69 - 74
  • [4] EXTENDED FOLLOW-UP OF THE CYCLOFA-LUNE TRIAL COMPARING TWO SEQUENTIAL INDUCTION AND MAINTENANCE TREATMENT REGIMENS FOR PROLIFERATIVE LUPUS NEPHRITIS BASED EITHER ON CYCLOPHOSPHAMIDE OR CYCLOSPORINE A
    Zavada, J.
    Pesickova, S. S.
    Rysava, R.
    Horak, P.
    Hrncir, Z.
    Lukac, J.
    Rovensky, J.
    Vitova, J.
    Bohmova, J.
    Havrda, M.
    Tegzova, D.
    Olejarova, M.
    Tesar, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 260 - 260
  • [5] Intravenous cyclophosphamide for the treatment of lupus nephritis
    Schwartzman, S
    Kirou, K
    Zuniga, R
    DelGiudiceAsch, G
    Peterson, M
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 157 - 157
  • [6] VCAM-1, thrombomodulin, anti C1Q antibodies and antinucleosome antibodies serum levels in lupus nephritis treated with Cyclosporine A or cyclophosphamide - Results from cyclofa-lune (2002) study
    Horak, P
    Hermanova, Z
    Budikova, M
    Dostal, C
    Tesar, V
    Zadrazil, J
    Rychlik, I
    Hrncir, Z
    Vlasakova, V
    Rovensky, J
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 241 - +
  • [7] Effectiveness of Intravenous Cyclophosphamide Treatment in Children with Lupus Nephritis
    Al, Isik Odaman
    SevincEmre
    IlmayBilge
    Alev
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1552 - 1552
  • [8] INTRAVENOUS CYCLOPHOSPHAMIDE (IVCY) FOR THE TREATMENT OF LUPUS NEPHRITIS (LN)
    SCHWARTZMAN, S
    DELGUIDICEASCH, G
    KIMBERLY, R
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 907 - 907
  • [9] Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis
    Feng Xuebing
    Gu Fei
    Chen Weiwei
    Liu Yan
    Wei Hua
    Liu Lin
    Yin Songlou
    Da Zhanyun
    Sun Lingyun
    中华医学杂志（英文版）, 2014, (21) : 3718 - 3723
  • [10] Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis
    Feng Xuebing
    Gu Fei
    Chen Weiwei
    Liu Yan
    Wei Hua
    Liu Lin
    Yin Songlou
    Da Zhanyun
    Sun Lingyun
    CHINESE MEDICAL JOURNAL, 2014, 127 (21) : 3718 - 3723
12345